84 88

Cited 11 times in

Transarterial Therapies for Hepatocellular Carcinoma

DC FieldValueLanguage
dc.contributor.author박영년-
dc.contributor.author이형진-
dc.date.accessioned2017-11-02T08:11:40Z-
dc.date.available2017-11-02T08:11:40Z-
dc.date.issued2017-
dc.identifier.issn2235-1795-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/154183-
dc.description.abstractBACKGROUND: The treatment of hepatocellular carcinoma (HCC) is still a major health issue because of its increasing incidence and because of the complexity of its management. Transarterial embolization (TAE) and transarterial chemoembolization (TACE) are two widely used locoregional therapies in the treatment of HCC, especially for unresectable intermediate and advanced HCCs. SUMMARY: The modern use of TAE and TACE opens new scenarios for the treatment of unresectable HCC and has yielded interesting results. The present work describes the role of transarterial therapies for HCC and focuses on the different Western and Eastern approaches to the study of response predictors. KEY MESSAGES: Recent refinements in interventional radiology techniques and in HCC patient selection have facilitated better local control of the disease. The molecular profiling of HCC to predict the response to TACE and TAE will greatly help clinicians identify the optimum therapy.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherS. Karger-
dc.relation.isPartOfLiver Cancer-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleTransarterial Therapies for Hepatocellular Carcinoma-
dc.typeArticle-
dc.publisher.locationSwitzerland-
dc.contributor.collegeCollege of Medicine-
dc.contributor.departmentDept. of Pathology-
dc.contributor.googleauthorEzio Lanza-
dc.contributor.googleauthorMatteo Donadon-
dc.contributor.googleauthorDario Poretti-
dc.contributor.googleauthorVittorio Pedicini-
dc.contributor.googleauthorMarco Tramarin-
dc.contributor.googleauthorMassimo Roncalli-
dc.contributor.googleauthorHyungjin Rhee-
dc.contributor.googleauthorYoung Nyun Park-
dc.contributor.googleauthorGuido Torzilli-
dc.identifier.doi10.1159/000449347-
dc.contributor.localIdA05171-
dc.contributor.localIdA01563-
dc.relation.journalcodeJ02170-
dc.identifier.pmid27995085-
dc.subject.keywordPredictors of response after TAE and TACE for HCC-
dc.subject.keywordTAE and TACE for HCC-
dc.contributor.alternativeNamePark, Young Nyun-
dc.contributor.alternativeNameRhee, Hyungjin-
dc.contributor.affiliatedAuthorRhee, Hyungjin-
dc.contributor.affiliatedAuthorPark, Young Nyun-
dc.citation.titleLiver Cancer-
dc.citation.volume6-
dc.citation.number1-
dc.citation.startPage27-
dc.citation.endPage33-
dc.identifier.bibliographicCitationLiver Cancer, Vol.6(1) : 27-33, 2017-
dc.date.modified2017-11-01-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.